• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy

    8/28/25 9:00:00 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care
    Get the next $OMDA alert in real time by email

    SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, released new data¹ demonstrating that patients who used Omada's virtual physical therapy (PT) program to address musculoskeletal (MSK) conditions, Omada for Joint & Muscle Health, had lower utilization of total medical care and reduced MSK-related costs and encounters on average at 6 and 12 months compared to patients who used in-person PT (IP-PT). This study is believed to be one of the first peer-reviewed healthcare claims analyses to compare costs and utilization of virtual PT (V-PT) and IP-PT in treating MSK conditions while also accounting for the cost of the virtual program itself.

    In the U.S., MSK conditions affect more than one in two adults and cost the healthcare system over $420 billion in 2018—more than cost of diabetes, heart disease, or any other chronic condition.² While physical therapy is often the first line of defense for MSK-related conditions³ ahead of costlier and higher-risk interventions like surgery, patients can face multiple barriers to accessing and participating in timely physical therapist care—geographic barriers, provider availability, and coverage restrictions like coinsurance or limits on the number of visits.⁴ Delays in starting PT treatment can add to downstream costs associated with care—like imaging and pain management—and increase the cost burden on individuals, employers, and health plans alike.⁵

    "Previous studies have shown that virtual physical therapy can reduce healthcare utilization and spending, but they have left out critical cost components," said Sarah Linke, PhD, MPH, Senior Director, Clinical & Translational Research, Omada Health. "Our findings demonstrate that Omada's human-led, virtual MSK program not only reduced direct service expenditures but also has the potential to be more cost-effective than in-person physical therapy over time, even after accounting for the cost of the program itself."

    Omada's study used Identity Manager, HealthVerity's patient de-identification and identity resolution technology, and claims data from July 2019 to May 2023, sourced from HealthVerity Marketplace™, to compare V-PT patients in Omada for Joint & Muscle Health to a control group of patients enrolled in IP-PT to analyze healthcare utilization, cost savings, and return on investment (ROI) at 6 and 12 months post-treatment initiation. As a partner to digital health innovators, HealthVerity works with companies like Omada to validate impact using a large, privacy-protected real-world data ecosystem.

    Omada's virtual MSK program was found to have a significant impact on all measures in the study when compared to controls, yielding a lower utilization of total medical care, driven in large part by a reduction in MSK-related costs and encounters. Median per-member-per-month savings were more than $100 in the first six months, with median gross MSK savings per member over $1,000 at both six and 12 months, reflecting a positive ROI (1.8x) at both six and 12 months.¹

    These savings are significant as research has shown that employers spend $353 billion annually on MSK-related treatments and conditions for their employees,⁶ which accounts for nearly 15% of their total medical costs.

    "For employers and health plans, this study is a significant indicator of the value of virtual MSK programs with meaningful ROI in just the first year," said Wei-Li Shao, President, Omada Health. "Given that those with chronic MSK pain have been found to be almost twice as likely as those without to have cardiovascular disease,⁶ we are well-positioned as a virtual-first, cardiometabolic care provider to provide high-quality MSK care to employers and payers who are consistently looking for ways to consolidate their offerings."

    Omada for Joint & Muscle Health has earned URAC for Telehealth accreditation, and provides treatments delivered by extensively trained, licensed physical therapists.

    "We're proud to contribute to Omada's growing body of peer-reviewed studies and to the broader industry literature, leveraging claims data to demonstrate the potential for virtual care programs, like Omada for Joint & Muscle Health, to deliver care that can be more cost-effective than traditional, in-person PT," said Ian Livingstone, Senior Director, Data Insights & Analytics, HealthVerity. "These findings highlight how real-world data can uncover the true impact of digital interventions on both patient outcomes and value-based care."

    Omada Health

    Omada Health is a virtual-first healthcare provider that nurtures lifelong health, one day at a time. Omada care teams implement clinically-validated behavior change protocols for individuals living with diabetes, hypertension, prediabetes, and musculoskeletal issues. With more than a decade of experience and data, and 30 peer-reviewed publications that showcase its clinical and economic results, Omada is designed to help improve health outcomes and contain healthcare costs. Omada's scope exceeds 2,000 customers, including health plans, health systems, and employers ranging in size from small businesses to Fortune 500s.

    The foundation of Omada's success is a strong, vibrant work culture, which helped earn the company the distinction of becoming an officially certified Great Place to Work®. An industry leader, Omada was the first virtual provider to join the Institute for Healthcare Improvement's Leadership Alliance, reflecting the aim to complement primary care providers for the benefit of members, and affirming its guarantee to every partner: Omada works differently.

    Contacts

    Rose Ramseth

    [email protected]

    Sources

    1. Napoleone, JM, Devaraj, SM, Noble, M, et al. Health Care Cost Savings and Utilization Reductions Associated With Virtual Physical Therapy Care: A Propensity-Matched Claims Analysis. Phys Ther. 2025;105(8). https://doi.org/10.1093/ptj/pzaf084
    2. The health care total cost of musculoskeletal conditions. Evernorth. August 3, 2022. Accessed July 22, 2025. https://www.evernorth.com/articles/health-care-total-cost-musculoskeletal-conditions.
    3. Lin I, Wiles L, Waller R, et al. What does best practice care for musculoskeletal pain look like? Eleven consistent recommendations from high-quality clinical practice guidelines: systematic review. British Journal of Sports Medicine. 2020;54:79-86.
    4. Carvalho E, Bettger JP, Goode AP. Insurance Coverage, Costs, and Barriers to Care for Outpatient Musculoskeletal Therapy and Rehabilitation Services. N C Med J. 2017 Sep-Oct;78(5):312-314. doi: 10.18043/ncm.78.5.312. PMID: 28963265; PMCID: PMC6021174.
    5. Addressing Musculoskeletal Conditions and Physical Therapy Needs with Virtual Solutions: Key Trends and Employer Considerations. Business Group on Health. November 15, 2024. Accessed July 22, 2025. https://www.businessgrouphealth.org/resources/addressing-musculoskeletal-conditions-and-physical-therapy-needs-with-virtual-solutions.
    6. Oliveira CB, Maher CG, Franco MR, Kamper SJ, Williams CM, Silva FG, Pinto RZ. Co-occurrence of Chronic Musculoskeletal Pain and Cardiovascular Diseases: A Systematic Review with Meta-analysis. Pain Med. 2020 Jun 1;21(6):1106-1121. doi: 10.1093/pm/pnz217. PMID: 31591645.


    Primary Logo

    Get the next $OMDA alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OMDA

    DatePrice TargetRatingAnalyst
    9/5/2025$24.00Neutral
    Robert W. Baird
    7/1/2025$21.00Outperform
    Evercore ISI
    7/1/2025$25.00Overweight
    Morgan Stanley
    7/1/2025$19.00Overweight
    Analyst
    7/1/2025$23.00Buy
    Needham
    7/1/2025$21.00Overweight
    Barclays
    7/1/2025$29.00Buy
    Goldman
    7/1/2025$27.00Buy
    Canaccord Genuity
    More analyst ratings

    $OMDA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions

    SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, released results from a real-world analysis that showed 63% of Omada members maintained or continued to lose weight 12 months after discontinuing GLP-1s,1 challenging widespread assumptions of inevitable post-medication weight regain. Since the GLP-1 Care Track launched, Omada has supported more than 100,000 members taking GLP-1 medications. The retrospective analysis included 816 members in Omada's GLP-1 Care Track and examined GLP-1 discontinuation and subsequent weight change at 6, 9, and 12 months.1 At one year post-discontinuation members showed just 0.8% ave

    9/8/25 9:00:00 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy

    SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, released new data¹ demonstrating that patients who used Omada's virtual physical therapy (PT) program to address musculoskeletal (MSK) conditions, Omada for Joint & Muscle Health, had lower utilization of total medical care and reduced MSK-related costs and encounters on average at 6 and 12 months compared to patients who used in-person PT (IP-PT). This study is believed to be one of the first peer-reviewed healthcare claims analyses to compare costs and utilization of virtual PT (V-PT) and IP-PT in treating MSK conditions while also accounting for the cost of the vir

    8/28/25 9:00:00 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    Omada Health to Participate in Upcoming Investor Conference

    SAN FRANCISCO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference, taking place in New York, including a fireside chat on Tuesday, September 9, 2025, at 5:35 pm ET. The webcast will be available online at https://investors.omadahealth.com/news-events/events. A replay will also be available at the same link following the event. About Omada Health Omada Health is a virtual-first healthcare provider that nurtures lifelong health, one day at a time. Omada care teams implement clinically-validated behavi

    8/26/25 9:00:00 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    $OMDA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Robert W. Baird initiated coverage on Omada Health with a new price target

    Robert W. Baird initiated coverage of Omada Health with a rating of Neutral and set a new price target of $24.00

    9/5/25 8:00:48 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    Evercore ISI initiated coverage on Omada Health with a new price target

    Evercore ISI initiated coverage of Omada Health with a rating of Outperform and set a new price target of $21.00

    7/1/25 8:41:36 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    Morgan Stanley initiated coverage on Omada Health with a new price target

    Morgan Stanley initiated coverage of Omada Health with a rating of Overweight and set a new price target of $25.00

    7/1/25 8:21:32 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    $OMDA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hilleman Jeryl L was granted 376 shares, increasing direct ownership by 4% to 10,112 units (SEC Form 4)

    4 - Omada Health, Inc. (0001611115) (Issuer)

    7/8/25 5:18:11 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    Director Root Jonathan D was granted 237 shares, increasing direct ownership by 2% to 9,973 units (SEC Form 4)

    4 - Omada Health, Inc. (0001611115) (Issuer)

    7/8/25 4:15:30 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    Director Fetter Trevor was granted 257 shares, increasing direct ownership by 3% to 9,993 units (SEC Form 4)

    4 - Omada Health, Inc. (0001611115) (Issuer)

    7/8/25 4:14:24 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    $OMDA
    Leadership Updates

    Live Leadership Updates

    View All

    New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions

    SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, released results from a real-world analysis that showed 63% of Omada members maintained or continued to lose weight 12 months after discontinuing GLP-1s,1 challenging widespread assumptions of inevitable post-medication weight regain. Since the GLP-1 Care Track launched, Omada has supported more than 100,000 members taking GLP-1 medications. The retrospective analysis included 816 members in Omada's GLP-1 Care Track and examined GLP-1 discontinuation and subsequent weight change at 6, 9, and 12 months.1 At one year post-discontinuation members showed just 0.8% ave

    9/8/25 9:00:00 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy

    SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, released new data¹ demonstrating that patients who used Omada's virtual physical therapy (PT) program to address musculoskeletal (MSK) conditions, Omada for Joint & Muscle Health, had lower utilization of total medical care and reduced MSK-related costs and encounters on average at 6 and 12 months compared to patients who used in-person PT (IP-PT). This study is believed to be one of the first peer-reviewed healthcare claims analyses to compare costs and utilization of virtual PT (V-PT) and IP-PT in treating MSK conditions while also accounting for the cost of the vir

    8/28/25 9:00:00 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    Omada Health's Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks

    SAN FRANCISCO, June 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, released new data1 demonstrating that Omada's GLP-1 companion program significantly improved persistence rates for GLP-1 medications. Evidence suggests that persistence on a GLP-1 is associated with greater weight loss.2 Omada's analysis found that those who persisted with their GLP-1 medication achieved weight loss results similar to what has been found in controlled research settings.1 Despite a growing body of evidence supporting vast clinical benefits of GLP-1s,3 while results vary widely, one study showed that one-third of people stopped taking their GLP-1 in

    6/17/25 9:00:00 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    $OMDA
    Financials

    Live finance-specific insights

    View All

    Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

    SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2025 results on Thursday, August 7, 2025, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details Those participating in the conference call can pre-register using the following link: https://register-conf.media-server.com/register/BIce129368a015484a8f39659a48a1631e. A live audio webcast of the call will also be available online at https://investors.omadahealth.com. A replay will be available shortly after the conclusion of the call at the same l

    7/17/25 4:30:00 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    $OMDA
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Omada Health Inc.

    SCHEDULE 13G - Omada Health, Inc. (0001611115) (Subject)

    8/14/25 4:17:07 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    SEC Form SCHEDULE 13G filed by Omada Health Inc.

    SCHEDULE 13G - Omada Health, Inc. (0001611115) (Subject)

    8/14/25 4:15:16 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by Omada Health Inc.

    10-Q - Omada Health, Inc. (0001611115) (Filer)

    8/8/25 4:16:56 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care